Ukubonelelwa nge-150 yezigidi zeeSeti zoVavanyo lweZinto ze-COVID-19! Kutheni le nto le nkampani yamkelwa ziifektri ze-IVD

Ukusukela nge2020, ishishini le-IVD lehlabathi liphenjelelwe ngamandla yi-COVID-19. Ngononophelo olukhulayo oluhlawulelweyo kuvavanyo lwe-nucleic acid kumazwe amaninzi, iinkampani ze-IVD aziphuhlisanga kuphela iimveliso zokubona ukuphefumla kodwa zisebenzise le teknoloji kuphuhliso kunye nokusetyenziswa kwezinye iimveliso zokufumanisa isifo.

I-TIANGEN, njengenkampani ekhokelayo kwicandelo lokuhlanjululwa kwe-asidi ye-acid kunye nomthengisi owaziwayo ngokubanzi wezinto ezingafunekiyo kwicandelo le-IVD, wazibonakalisa e-China (e-Shanghai) kwiMpilo kaRhulumente, kuthintelo lobhubhane kunye neMiboniso yezixhobo ezikhuselayo kunye neMiboniso yokungenisa nokuthumela ngaphandle (i-Shanghai Efanelekileyo) ngo-2021 kunye nesisombululo sayo sokufumanisa intsholongwane. Kwi-Fair, I-TIANGEN ikwenze nzulu ukuqonda kunye nentsebenziswano kunye nabathengi beenkampani ze-IVD ekhaya nakumazwe aphesheya kunye nokukhuthaza iinkampani ze-IVD ukufezekisa ukukhula ngokukhawuleza kwixesha lasemva kobhubhane.

Ukusukela ngo-2020, i-TIANGEN ibonelele ngaphezulu kwe-20 yezigidi zovavanyo lwee-rectents zokukhupha i-acid ye-acid, ngaphezulu kwe-150 yezigidi zovavanyo lwezixhobo zokwenza imveliso kunye namakhulu ezinto ezizenzekelayo ze-nucleic acid zokuthintela, ukulawula kunye nokuvavanya i-COVID-19.

news

Izinto zokuvelisa intsholongwane ye-TIANGEN ziye zaqatshelwa ngamashishini amaninzi awaziwayo e-IVD ekhaya nakumazwe aphesheya. Kwi-WHO yoSetyenziso oluNgxamisekileyo lokuVavanya isifo seCoronavirus (i-COVID-19) IVDs INGXELO YOLUNTU ekhutshwe ngoJuni 2020, i-TIANGEN nucleic acid yokutsala ikiti yadweliswa njengemveliso ekucetyiswa ukuba ikhutshwe i-nucleic acid kwi-COVID-19. Kuluhlu oluCetyiswayo lokuchonga iiReagents kwi-COVID-19 epapashwe yiNgxowa-mali yeHlabathi ngoJanuwari ka-2021, iimveliso zeTIANGEN zidweliswe njengezinto ezingafunekiyo zamashishini amaninzi ekhaya nakwamanye amazwe.

I-TIANGEN, ixhotyiswe ngemfundo egqibeleleyo yokuthumela kwelinye ilizwe kunye nenkqubo yeshishini, yandisile ishishini lamazwe aphesheya kumazwe angaphezu kwama-40 kunye nemimandla, kubandakanya iJapan, iSingapore, iFrance, iArgentina, iKenya, njl. amashishini ukuya kumhlaba jikelele ngokubanzi kunye nokudlala indima ebaluleke kakhulu ekukhuthazeni uphuhliso lokhathalelo lwempilo lwabantu bonke.

news
news

I-TIANGEN inamava angaphezulu kweminyaka elishumi ekukhonzeni i-IVD yeshishini ngeendlela ezahlukeneyo zokubambisana ezifanelekileyo kubathengi beshishini. Iqela lenkonzo yobungcali liza kusekwa ngokudibanisa iinkokheli ze-R & D, itekhnoloji kunye neprojekthi yoyilo kunye nokubonelela ngezikimu ezahlukeneyo zokusebenzisana ngokweemfuno zabathengi. Le modeli yenzelwe ukunceda abathengi ekusombululeni iingxaki ekujongenwe nazo kwi-R & D kunye nemveliso kunye nokubonelela abathengi ngesisombululo esenziwe ngokwezifiso ezifanelekileyo ngakumbi kuphuhliso lwexesha elizayo.

Kwi China (Shanghai) yeTekhnoloji yeLizwe yeTekhnoloji kulo nyaka, I-TIANGEN ayizisanga kuphela i-high-throughput ngokuzenzekelayo ye-nucleic acid extractors kunye ne-auto pipetting workstation kodwa kunye neemveliso ezenziwayo kunye nezinto ezingavunyelwanga kuvavanyo lwe-SARS-COV2, notsale amashishini e-IVD asekhaya nakwamanye amazwe. kuMbutho ukunxibelelana.

news
news

I-TIANGEN ibisoloko inikezela ngezinto ezikrwada ezikumgangatho ophezulu kunye nezisombululo ezizenzekelayo zabavelisi bezinto zokuxilonga, iziko lophando lwezonyango, i-CDC kunye nezinye iiyunithi zesicelo kunye nokubonelela ngezisombululo ezahlukeneyo zophando lwebhayoloji kwiiyunivesithi, kumaziko ophando nakwamanye amaziko ophando lwenzululwazi.

Kwixesha lasemva kobhubhane, I-TIANGEN iya kubonelela ngamashishini e-IVD ngezisombululo ezitsha zovavanyo lwe-pathogen nucleic acid kunye nezinye iindlela zokuchonga iimolekyuli kwaye zisebenzisana nawo onke amaqabane ukunceda amaqabane ukuphucula ukhuphiswano lwawo kwintengiso yamanye amazwe kwaye ngokudibeneyo yamkela imingeni ezayo .


Ixesha lokuposa: Mar-21-2021